DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2012; 137(31/32): 1568-1572DOI: 10.1055/s-0032-1305187 Kardiologie | Commentary Kardiologie, Geburtshilfe © Georg Thieme Verlag KG Stuttgart · New York Kardiovaskuläre Erkrankungen in der Schwangerschaft: Die wichtigsten Fakten der neuen Leitlinie Cardiovascular diseases in pregnancy: facts of the new guideline U. Seeland 1 Institut für Geschlechterforschung in der Medizin (GIM), Charité-Universitätsmedizin Berlin Campus Mitte , P. Goldin-Lang 1 Institut für Geschlechterforschung in der Medizin (GIM), Charité-Universitätsmedizin Berlin Campus Mitte , V. Regitz-Zagrosek 1 Institut für Geschlechterforschung in der Medizin (GIM), Charité-Universitätsmedizin Berlin Campus Mitte › Author Affiliations Recommend Article Abstract Buy Article Schlüsselwörter Schlüsselwörterkardiovaskuläre Erkrankungen - Schwangerschaft - angeborene Herzfehler - Hypertonie - Antikoagulation Keywords Keywordscardiovascular diseases - pregnancy - congenital heart disease - arterial hypertension - anticoagulation Full Text References Literatur 1 Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Amer J Obstet Gynecol 2000; 183: 1-S22 2 Balint OH, Siu SC, Mason J et al. Cardiac outcomes after pregnancy in women with congenital heart disease. Heart 2010; 96: 1656-1661 3 Castellano JM, Narayan RL, Vaishnava P et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol 2012; 9: 415-424 4 Coppage KH, Sibai BM. Treatment of hypertensive complications in pregnancy. Current Pharm Design 2005; 11: 749-757 5 Drenthen W, Boersma E, Balci A et al. Predictors of pregnancy complications in women with congenital heart disease. Europ Heart J 2010; 31: 2124-2132 6 Friedrich E, Hameed AB. Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol 2010; 30: 253-257 7 Genoni M, Jenni R, Hoerstrup SP et al. Pregnancy after atrial repair for transposition of the great arteries. Heart 1999; 81: 276-277 8 Meijboom LJ, Vos FE, Timmermans J et al. Pregnancy and aortic root growth in the Marfan syndrome. Europ Heart J 2005; 26: 914-920 9 O'Connor DJ, Scher LA, Gargiulo 3rd NJ et al. Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series. Ann Vasc Surg 2011; 25: 9-14 10 O'Donoghue M, Boden WE, Braunwald E et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction. JAMA 2008; 300: 71-80 11 Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008; 51: 960-969 12 Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Europ Heart J 2011; 32: 3147 und http://www.escardio.org/guidelines-surveys/ esc-guidelines/GuidelinesDocuments/ Guidelines-Pregnancy-FT.pdf 13 Sillesen M, Hjortdal V, Vejlstrup N et al. Pregnancy with prosthetic heart valves – 30 years' nationwide experience in Denmark. Europ J Cardio-thorac Surg 2011; 40: 448-454 14 Sliwa K, Blauwet L, Tibazarwa K et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy. Circulation 2010; 121: 1465-1473 15 Sliwa K, Hilfiker-Kleiner D, Petrie MC et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Europ J Heart Failure 2010; 12: 767-778 16 Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006; 92: 1520-152
